XML 26 R15.htm IDEA: XBRL DOCUMENT

CONCENTRATIONS

9 Months Ended

Sep. 30, 2018

(10)

CONCENTRATIONS

For the three months ended September 30, 2018, the Company sourced approximately 51% of the components for its electrotherapy products from three significant vendors (defined as supplying at least 10%). For the nine months ended September 30, 2018 the company sourced approximately 44% of components from one significant supplier.

For the three months ended September 30, 2017, the Company sourced approximately 52% from three significant vendors. For the nine months ended September 30, 2017, the Company sourced 47% of its components from two significant vendors.

Management believes that its relationships with suppliers are good; however, if the relationships were to be replaced, there may be a short-term disruption to operations, a period of time in which products may not be available and additional expenses may be incurred.

The Company had receivables from a private health insurance carrier at September 30, 2018 and December 31, 2017, that made up approximately 22% and 24%, respectively, of the net accounts receivable balance.